nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—stomach cancer	0.45	1	CbGaD
Ezogabine—UGT1A9—Irinotecan—stomach cancer	0.122	0.438	CbGbCtD
Ezogabine—UGT1A1—Irinotecan—stomach cancer	0.0997	0.358	CbGbCtD
Ezogabine—CYP2A6—Fluorouracil—stomach cancer	0.0568	0.204	CbGbCtD
Ezogabine—UGT1A4—hematopoietic system—stomach cancer	0.00266	0.0907	CbGeAlD
Ezogabine—NAT2—endocrine gland—stomach cancer	0.00238	0.0809	CbGeAlD
Ezogabine—UGT1A3—digestive system—stomach cancer	0.00218	0.0742	CbGeAlD
Ezogabine—NAT2—liver—stomach cancer	0.00214	0.0729	CbGeAlD
Ezogabine—UGT1A4—digestive system—stomach cancer	0.00185	0.0631	CbGeAlD
Ezogabine—UGT1A3—endocrine gland—stomach cancer	0.0018	0.0613	CbGeAlD
Ezogabine—UGT1A3—liver—stomach cancer	0.00162	0.0553	CbGeAlD
Ezogabine—UGT1A9—digestive system—stomach cancer	0.00155	0.0529	CbGeAlD
Ezogabine—UGT1A4—endocrine gland—stomach cancer	0.00153	0.0521	CbGeAlD
Ezogabine—UGT1A1—hematopoietic system—stomach cancer	0.00153	0.0521	CbGeAlD
Ezogabine—KCNQ2—endocrine gland—stomach cancer	0.00149	0.0508	CbGeAlD
Ezogabine—KCNQ5—lymph node—stomach cancer	0.0014	0.0476	CbGeAlD
Ezogabine—UGT1A4—liver—stomach cancer	0.00138	0.047	CbGeAlD
Ezogabine—UGT1A9—endocrine gland—stomach cancer	0.00128	0.0437	CbGeAlD
Ezogabine—UGT1A9—liver—stomach cancer	0.00116	0.0394	CbGeAlD
Ezogabine—UGT1A1—digestive system—stomach cancer	0.00106	0.0362	CbGeAlD
Ezogabine—UGT1A1—endocrine gland—stomach cancer	0.000879	0.0299	CbGeAlD
Ezogabine—UGT1A1—liver—stomach cancer	0.000793	0.027	CbGeAlD
Ezogabine—CYP2A6—liver—stomach cancer	0.000668	0.0228	CbGeAlD
Ezogabine—Leukopenia—Fluorouracil—stomach cancer	0.000316	0.00225	CcSEcCtD
Ezogabine—Infestation NOS—Capecitabine—stomach cancer	0.000316	0.00225	CcSEcCtD
Ezogabine—Infestation—Capecitabine—stomach cancer	0.000316	0.00225	CcSEcCtD
Ezogabine—Discomfort—Irinotecan—stomach cancer	0.000311	0.00221	CcSEcCtD
Ezogabine—Hepatobiliary disease—Docetaxel—stomach cancer	0.000309	0.0022	CcSEcCtD
Ezogabine—Osteoarthritis—Methotrexate—stomach cancer	0.000305	0.00217	CcSEcCtD
Ezogabine—Increased appetite—Epirubicin—stomach cancer	0.000304	0.00216	CcSEcCtD
Ezogabine—Confusional state—Irinotecan—stomach cancer	0.000304	0.00216	CcSEcCtD
Ezogabine—Haematuria—Capecitabine—stomach cancer	0.000301	0.00214	CcSEcCtD
Ezogabine—Infection—Irinotecan—stomach cancer	0.000299	0.00213	CcSEcCtD
Ezogabine—Hepatobiliary disease—Capecitabine—stomach cancer	0.000299	0.00213	CcSEcCtD
Ezogabine—Discomfort—Fluorouracil—stomach cancer	0.000297	0.00211	CcSEcCtD
Ezogabine—Shock—Irinotecan—stomach cancer	0.000296	0.00211	CcSEcCtD
Ezogabine—Nervous system disorder—Irinotecan—stomach cancer	0.000295	0.0021	CcSEcCtD
Ezogabine—Thrombocytopenia—Irinotecan—stomach cancer	0.000295	0.0021	CcSEcCtD
Ezogabine—Hyperhidrosis—Irinotecan—stomach cancer	0.000291	0.00207	CcSEcCtD
Ezogabine—Confusional state—Fluorouracil—stomach cancer	0.000291	0.00207	CcSEcCtD
Ezogabine—Urinary tract disorder—Docetaxel—stomach cancer	0.00029	0.00206	CcSEcCtD
Ezogabine—Oedema peripheral—Docetaxel—stomach cancer	0.000289	0.00205	CcSEcCtD
Ezogabine—Urethral disorder—Docetaxel—stomach cancer	0.000287	0.00204	CcSEcCtD
Ezogabine—Infection—Fluorouracil—stomach cancer	0.000287	0.00204	CcSEcCtD
Ezogabine—Diplopia—Epirubicin—stomach cancer	0.000286	0.00203	CcSEcCtD
Ezogabine—Osteoarthritis—Epirubicin—stomach cancer	0.000286	0.00203	CcSEcCtD
Ezogabine—Nervous system disorder—Fluorouracil—stomach cancer	0.000283	0.00201	CcSEcCtD
Ezogabine—Thrombocytopenia—Fluorouracil—stomach cancer	0.000283	0.00201	CcSEcCtD
Ezogabine—Visual impairment—Docetaxel—stomach cancer	0.000283	0.00201	CcSEcCtD
Ezogabine—Liver function test abnormal—Methotrexate—stomach cancer	0.000282	0.002	CcSEcCtD
Ezogabine—Increased appetite—Doxorubicin—stomach cancer	0.000281	0.002	CcSEcCtD
Ezogabine—Urinary tract disorder—Capecitabine—stomach cancer	0.00028	0.00199	CcSEcCtD
Ezogabine—Oedema peripheral—Capecitabine—stomach cancer	0.00028	0.00199	CcSEcCtD
Ezogabine—Urethral disorder—Capecitabine—stomach cancer	0.000278	0.00198	CcSEcCtD
Ezogabine—Eye disorder—Docetaxel—stomach cancer	0.000274	0.00195	CcSEcCtD
Ezogabine—Visual impairment—Capecitabine—stomach cancer	0.000274	0.00194	CcSEcCtD
Ezogabine—Paraesthesia—Irinotecan—stomach cancer	0.000271	0.00192	CcSEcCtD
Ezogabine—Dyspnoea—Irinotecan—stomach cancer	0.000269	0.00191	CcSEcCtD
Ezogabine—Somnolence—Irinotecan—stomach cancer	0.000268	0.0019	CcSEcCtD
Ezogabine—Eye disorder—Capecitabine—stomach cancer	0.000265	0.00189	CcSEcCtD
Ezogabine—Dyspepsia—Irinotecan—stomach cancer	0.000265	0.00189	CcSEcCtD
Ezogabine—Osteoarthritis—Doxorubicin—stomach cancer	0.000264	0.00188	CcSEcCtD
Ezogabine—Diplopia—Doxorubicin—stomach cancer	0.000264	0.00188	CcSEcCtD
Ezogabine—Liver function test abnormal—Epirubicin—stomach cancer	0.000264	0.00188	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00026	0.00185	CcSEcCtD
Ezogabine—Fatigue—Irinotecan—stomach cancer	0.00026	0.00185	CcSEcCtD
Ezogabine—Paraesthesia—Fluorouracil—stomach cancer	0.000259	0.00184	CcSEcCtD
Ezogabine—Alopecia—Docetaxel—stomach cancer	0.000259	0.00184	CcSEcCtD
Ezogabine—Constipation—Irinotecan—stomach cancer	0.000258	0.00183	CcSEcCtD
Ezogabine—Dyspnoea—Fluorouracil—stomach cancer	0.000257	0.00183	CcSEcCtD
Ezogabine—Mental disorder—Docetaxel—stomach cancer	0.000257	0.00183	CcSEcCtD
Ezogabine—Somnolence—Fluorouracil—stomach cancer	0.000257	0.00182	CcSEcCtD
Ezogabine—Malnutrition—Docetaxel—stomach cancer	0.000255	0.00181	CcSEcCtD
Ezogabine—Dyspepsia—Fluorouracil—stomach cancer	0.000254	0.00181	CcSEcCtD
Ezogabine—Alopecia—Capecitabine—stomach cancer	0.000251	0.00178	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000249	0.00177	CcSEcCtD
Ezogabine—Mental disorder—Capecitabine—stomach cancer	0.000249	0.00177	CcSEcCtD
Ezogabine—Feeling abnormal—Irinotecan—stomach cancer	0.000248	0.00176	CcSEcCtD
Ezogabine—Malnutrition—Capecitabine—stomach cancer	0.000247	0.00176	CcSEcCtD
Ezogabine—Influenza—Epirubicin—stomach cancer	0.000247	0.00176	CcSEcCtD
Ezogabine—Dysphagia—Epirubicin—stomach cancer	0.000247	0.00176	CcSEcCtD
Ezogabine—Neutropenia—Methotrexate—stomach cancer	0.000247	0.00175	CcSEcCtD
Ezogabine—Dysuria—Methotrexate—stomach cancer	0.000247	0.00175	CcSEcCtD
Ezogabine—Muscle spasms—Docetaxel—stomach cancer	0.000245	0.00174	CcSEcCtD
Ezogabine—Liver function test abnormal—Doxorubicin—stomach cancer	0.000244	0.00174	CcSEcCtD
Ezogabine—Feeling abnormal—Fluorouracil—stomach cancer	0.000238	0.00169	CcSEcCtD
Ezogabine—Muscle spasms—Capecitabine—stomach cancer	0.000238	0.00169	CcSEcCtD
Ezogabine—Infestation NOS—Methotrexate—stomach cancer	0.000235	0.00167	CcSEcCtD
Ezogabine—Infestation—Methotrexate—stomach cancer	0.000235	0.00167	CcSEcCtD
Ezogabine—Vision blurred—Capecitabine—stomach cancer	0.000233	0.00166	CcSEcCtD
Ezogabine—Tremor—Capecitabine—stomach cancer	0.000231	0.00165	CcSEcCtD
Ezogabine—Dysuria—Epirubicin—stomach cancer	0.000231	0.00164	CcSEcCtD
Ezogabine—Neutropenia—Epirubicin—stomach cancer	0.000231	0.00164	CcSEcCtD
Ezogabine—Ill-defined disorder—Capecitabine—stomach cancer	0.000229	0.00163	CcSEcCtD
Ezogabine—Syncope—Docetaxel—stomach cancer	0.000229	0.00163	CcSEcCtD
Ezogabine—Dysphagia—Doxorubicin—stomach cancer	0.000229	0.00162	CcSEcCtD
Ezogabine—Influenza—Doxorubicin—stomach cancer	0.000229	0.00162	CcSEcCtD
Ezogabine—Leukopenia—Docetaxel—stomach cancer	0.000228	0.00162	CcSEcCtD
Ezogabine—Weight increased—Epirubicin—stomach cancer	0.000225	0.0016	CcSEcCtD
Ezogabine—Haematuria—Methotrexate—stomach cancer	0.000224	0.0016	CcSEcCtD
Ezogabine—Loss of consciousness—Docetaxel—stomach cancer	0.000224	0.00159	CcSEcCtD
Ezogabine—Malaise—Capecitabine—stomach cancer	0.000223	0.00158	CcSEcCtD
Ezogabine—Hepatobiliary disease—Methotrexate—stomach cancer	0.000223	0.00158	CcSEcCtD
Ezogabine—Vertigo—Capecitabine—stomach cancer	0.000222	0.00158	CcSEcCtD
Ezogabine—Syncope—Capecitabine—stomach cancer	0.000222	0.00157	CcSEcCtD
Ezogabine—Leukopenia—Capecitabine—stomach cancer	0.000221	0.00157	CcSEcCtD
Ezogabine—Infestation NOS—Epirubicin—stomach cancer	0.00022	0.00157	CcSEcCtD
Ezogabine—Infestation—Epirubicin—stomach cancer	0.00022	0.00157	CcSEcCtD
Ezogabine—Loss of consciousness—Capecitabine—stomach cancer	0.000217	0.00154	CcSEcCtD
Ezogabine—Asthenia—Irinotecan—stomach cancer	0.000216	0.00154	CcSEcCtD
Ezogabine—Neutropenia—Doxorubicin—stomach cancer	0.000214	0.00152	CcSEcCtD
Ezogabine—Dysuria—Doxorubicin—stomach cancer	0.000214	0.00152	CcSEcCtD
Ezogabine—Dry mouth—Docetaxel—stomach cancer	0.000212	0.00151	CcSEcCtD
Ezogabine—Haematuria—Epirubicin—stomach cancer	0.00021	0.00149	CcSEcCtD
Ezogabine—Confusional state—Docetaxel—stomach cancer	0.00021	0.00149	CcSEcCtD
Ezogabine—Anxiety—Capecitabine—stomach cancer	0.00021	0.00149	CcSEcCtD
Ezogabine—Urinary tract disorder—Methotrexate—stomach cancer	0.000209	0.00148	CcSEcCtD
Ezogabine—Hepatobiliary disease—Epirubicin—stomach cancer	0.000208	0.00148	CcSEcCtD
Ezogabine—Weight increased—Doxorubicin—stomach cancer	0.000208	0.00148	CcSEcCtD
Ezogabine—Discomfort—Capecitabine—stomach cancer	0.000208	0.00148	CcSEcCtD
Ezogabine—Urethral disorder—Methotrexate—stomach cancer	0.000207	0.00147	CcSEcCtD
Ezogabine—Infection—Docetaxel—stomach cancer	0.000207	0.00147	CcSEcCtD
Ezogabine—Dry mouth—Capecitabine—stomach cancer	0.000206	0.00146	CcSEcCtD
Ezogabine—Shock—Docetaxel—stomach cancer	0.000205	0.00146	CcSEcCtD
Ezogabine—Nervous system disorder—Docetaxel—stomach cancer	0.000204	0.00145	CcSEcCtD
Ezogabine—Thrombocytopenia—Docetaxel—stomach cancer	0.000204	0.00145	CcSEcCtD
Ezogabine—Infestation NOS—Doxorubicin—stomach cancer	0.000204	0.00145	CcSEcCtD
Ezogabine—Infestation—Doxorubicin—stomach cancer	0.000204	0.00145	CcSEcCtD
Ezogabine—Visual impairment—Methotrexate—stomach cancer	0.000204	0.00145	CcSEcCtD
Ezogabine—Confusional state—Capecitabine—stomach cancer	0.000203	0.00145	CcSEcCtD
Ezogabine—Infection—Capecitabine—stomach cancer	0.0002	0.00142	CcSEcCtD
Ezogabine—Dizziness—Irinotecan—stomach cancer	0.000199	0.00142	CcSEcCtD
Ezogabine—Shock—Capecitabine—stomach cancer	0.000198	0.00141	CcSEcCtD
Ezogabine—Nervous system disorder—Capecitabine—stomach cancer	0.000198	0.00141	CcSEcCtD
Ezogabine—Eye disorder—Methotrexate—stomach cancer	0.000197	0.0014	CcSEcCtD
Ezogabine—Thrombocytopenia—Capecitabine—stomach cancer	0.000197	0.0014	CcSEcCtD
Ezogabine—Urinary tract disorder—Epirubicin—stomach cancer	0.000195	0.00139	CcSEcCtD
Ezogabine—Hyperhidrosis—Capecitabine—stomach cancer	0.000195	0.00139	CcSEcCtD
Ezogabine—Oedema peripheral—Epirubicin—stomach cancer	0.000195	0.00138	CcSEcCtD
Ezogabine—Haematuria—Doxorubicin—stomach cancer	0.000194	0.00138	CcSEcCtD
Ezogabine—Urethral disorder—Epirubicin—stomach cancer	0.000194	0.00138	CcSEcCtD
Ezogabine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000193	0.00137	CcSEcCtD
Ezogabine—Dizziness—Fluorouracil—stomach cancer	0.000191	0.00136	CcSEcCtD
Ezogabine—Visual impairment—Epirubicin—stomach cancer	0.000191	0.00135	CcSEcCtD
Ezogabine—Rash—Irinotecan—stomach cancer	0.00019	0.00135	CcSEcCtD
Ezogabine—Dermatitis—Irinotecan—stomach cancer	0.00019	0.00135	CcSEcCtD
Ezogabine—Paraesthesia—Docetaxel—stomach cancer	0.000187	0.00133	CcSEcCtD
Ezogabine—Alopecia—Methotrexate—stomach cancer	0.000187	0.00133	CcSEcCtD
Ezogabine—Dyspnoea—Docetaxel—stomach cancer	0.000186	0.00132	CcSEcCtD
Ezogabine—Somnolence—Docetaxel—stomach cancer	0.000185	0.00132	CcSEcCtD
Ezogabine—Mental disorder—Methotrexate—stomach cancer	0.000185	0.00132	CcSEcCtD
Ezogabine—Eye disorder—Epirubicin—stomach cancer	0.000185	0.00131	CcSEcCtD
Ezogabine—Malnutrition—Methotrexate—stomach cancer	0.000184	0.00131	CcSEcCtD
Ezogabine—Dyspepsia—Docetaxel—stomach cancer	0.000183	0.0013	CcSEcCtD
Ezogabine—Rash—Fluorouracil—stomach cancer	0.000182	0.00129	CcSEcCtD
Ezogabine—Dermatitis—Fluorouracil—stomach cancer	0.000182	0.00129	CcSEcCtD
Ezogabine—Paraesthesia—Capecitabine—stomach cancer	0.000181	0.00129	CcSEcCtD
Ezogabine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000181	0.00128	CcSEcCtD
Ezogabine—Oedema peripheral—Doxorubicin—stomach cancer	0.00018	0.00128	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00018	0.00128	CcSEcCtD
Ezogabine—Dyspnoea—Capecitabine—stomach cancer	0.00018	0.00128	CcSEcCtD
Ezogabine—Fatigue—Docetaxel—stomach cancer	0.00018	0.00128	CcSEcCtD
Ezogabine—Urethral disorder—Doxorubicin—stomach cancer	0.000179	0.00127	CcSEcCtD
Ezogabine—Nausea—Irinotecan—stomach cancer	0.000179	0.00127	CcSEcCtD
Ezogabine—Constipation—Docetaxel—stomach cancer	0.000178	0.00127	CcSEcCtD
Ezogabine—Dyspepsia—Capecitabine—stomach cancer	0.000178	0.00126	CcSEcCtD
Ezogabine—Visual impairment—Doxorubicin—stomach cancer	0.000176	0.00125	CcSEcCtD
Ezogabine—Alopecia—Epirubicin—stomach cancer	0.000175	0.00124	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000174	0.00124	CcSEcCtD
Ezogabine—Fatigue—Capecitabine—stomach cancer	0.000174	0.00124	CcSEcCtD
Ezogabine—Vision blurred—Methotrexate—stomach cancer	0.000173	0.00123	CcSEcCtD
Ezogabine—Mental disorder—Epirubicin—stomach cancer	0.000173	0.00123	CcSEcCtD
Ezogabine—Constipation—Capecitabine—stomach cancer	0.000172	0.00123	CcSEcCtD
Ezogabine—Malnutrition—Epirubicin—stomach cancer	0.000172	0.00122	CcSEcCtD
Ezogabine—Feeling abnormal—Docetaxel—stomach cancer	0.000172	0.00122	CcSEcCtD
Ezogabine—Nausea—Fluorouracil—stomach cancer	0.000171	0.00122	CcSEcCtD
Ezogabine—Eye disorder—Doxorubicin—stomach cancer	0.000171	0.00122	CcSEcCtD
Ezogabine—Ill-defined disorder—Methotrexate—stomach cancer	0.000171	0.00121	CcSEcCtD
Ezogabine—Feeling abnormal—Capecitabine—stomach cancer	0.000166	0.00118	CcSEcCtD
Ezogabine—Malaise—Methotrexate—stomach cancer	0.000166	0.00118	CcSEcCtD
Ezogabine—Muscle spasms—Epirubicin—stomach cancer	0.000165	0.00118	CcSEcCtD
Ezogabine—Vertigo—Methotrexate—stomach cancer	0.000165	0.00117	CcSEcCtD
Ezogabine—Leukopenia—Methotrexate—stomach cancer	0.000165	0.00117	CcSEcCtD
Ezogabine—Vision blurred—Epirubicin—stomach cancer	0.000162	0.00115	CcSEcCtD
Ezogabine—Alopecia—Doxorubicin—stomach cancer	0.000162	0.00115	CcSEcCtD
Ezogabine—Mental disorder—Doxorubicin—stomach cancer	0.00016	0.00114	CcSEcCtD
Ezogabine—Ill-defined disorder—Epirubicin—stomach cancer	0.00016	0.00114	CcSEcCtD
Ezogabine—Malnutrition—Doxorubicin—stomach cancer	0.000159	0.00113	CcSEcCtD
Ezogabine—Malaise—Epirubicin—stomach cancer	0.000155	0.0011	CcSEcCtD
Ezogabine—Discomfort—Methotrexate—stomach cancer	0.000155	0.0011	CcSEcCtD
Ezogabine—Vertigo—Epirubicin—stomach cancer	0.000155	0.0011	CcSEcCtD
Ezogabine—Syncope—Epirubicin—stomach cancer	0.000154	0.0011	CcSEcCtD
Ezogabine—Leukopenia—Epirubicin—stomach cancer	0.000154	0.0011	CcSEcCtD
Ezogabine—Muscle spasms—Doxorubicin—stomach cancer	0.000153	0.00109	CcSEcCtD
Ezogabine—Confusional state—Methotrexate—stomach cancer	0.000151	0.00108	CcSEcCtD
Ezogabine—Loss of consciousness—Epirubicin—stomach cancer	0.000151	0.00108	CcSEcCtD
Ezogabine—Vision blurred—Doxorubicin—stomach cancer	0.00015	0.00107	CcSEcCtD
Ezogabine—Asthenia—Docetaxel—stomach cancer	0.000149	0.00106	CcSEcCtD
Ezogabine—Infection—Methotrexate—stomach cancer	0.000149	0.00106	CcSEcCtD
Ezogabine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000148	0.00105	CcSEcCtD
Ezogabine—Nervous system disorder—Methotrexate—stomach cancer	0.000147	0.00105	CcSEcCtD
Ezogabine—Thrombocytopenia—Methotrexate—stomach cancer	0.000147	0.00104	CcSEcCtD
Ezogabine—Anxiety—Epirubicin—stomach cancer	0.000146	0.00104	CcSEcCtD
Ezogabine—Hyperhidrosis—Methotrexate—stomach cancer	0.000145	0.00103	CcSEcCtD
Ezogabine—Discomfort—Epirubicin—stomach cancer	0.000145	0.00103	CcSEcCtD
Ezogabine—Asthenia—Capecitabine—stomach cancer	0.000145	0.00103	CcSEcCtD
Ezogabine—Malaise—Doxorubicin—stomach cancer	0.000144	0.00102	CcSEcCtD
Ezogabine—Dry mouth—Epirubicin—stomach cancer	0.000143	0.00102	CcSEcCtD
Ezogabine—Vertigo—Doxorubicin—stomach cancer	0.000143	0.00102	CcSEcCtD
Ezogabine—Syncope—Doxorubicin—stomach cancer	0.000143	0.00102	CcSEcCtD
Ezogabine—Leukopenia—Doxorubicin—stomach cancer	0.000143	0.00101	CcSEcCtD
Ezogabine—Confusional state—Epirubicin—stomach cancer	0.000142	0.00101	CcSEcCtD
Ezogabine—Loss of consciousness—Doxorubicin—stomach cancer	0.00014	0.000995	CcSEcCtD
Ezogabine—Infection—Epirubicin—stomach cancer	0.00014	0.000992	CcSEcCtD
Ezogabine—Shock—Epirubicin—stomach cancer	0.000138	0.000982	CcSEcCtD
Ezogabine—Nervous system disorder—Epirubicin—stomach cancer	0.000138	0.000979	CcSEcCtD
Ezogabine—Dizziness—Docetaxel—stomach cancer	0.000138	0.000979	CcSEcCtD
Ezogabine—Thrombocytopenia—Epirubicin—stomach cancer	0.000138	0.000978	CcSEcCtD
Ezogabine—Hyperhidrosis—Epirubicin—stomach cancer	0.000136	0.000965	CcSEcCtD
Ezogabine—Anxiety—Doxorubicin—stomach cancer	0.000135	0.00096	CcSEcCtD
Ezogabine—Paraesthesia—Methotrexate—stomach cancer	0.000135	0.000958	CcSEcCtD
Ezogabine—Discomfort—Doxorubicin—stomach cancer	0.000134	0.000952	CcSEcCtD
Ezogabine—Dyspnoea—Methotrexate—stomach cancer	0.000134	0.000951	CcSEcCtD
Ezogabine—Somnolence—Methotrexate—stomach cancer	0.000133	0.000949	CcSEcCtD
Ezogabine—Dizziness—Capecitabine—stomach cancer	0.000133	0.000948	CcSEcCtD
Ezogabine—Dry mouth—Doxorubicin—stomach cancer	0.000133	0.000943	CcSEcCtD
Ezogabine—Dyspepsia—Methotrexate—stomach cancer	0.000132	0.000939	CcSEcCtD
Ezogabine—Rash—Docetaxel—stomach cancer	0.000131	0.000933	CcSEcCtD
Ezogabine—Dermatitis—Docetaxel—stomach cancer	0.000131	0.000933	CcSEcCtD
Ezogabine—Confusional state—Doxorubicin—stomach cancer	0.000131	0.000932	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00013	0.000921	CcSEcCtD
Ezogabine—Fatigue—Methotrexate—stomach cancer	0.000129	0.00092	CcSEcCtD
Ezogabine—Infection—Doxorubicin—stomach cancer	0.000129	0.000918	CcSEcCtD
Ezogabine—Shock—Doxorubicin—stomach cancer	0.000128	0.000909	CcSEcCtD
Ezogabine—Nervous system disorder—Doxorubicin—stomach cancer	0.000127	0.000906	CcSEcCtD
Ezogabine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000127	0.000905	CcSEcCtD
Ezogabine—Rash—Capecitabine—stomach cancer	0.000127	0.000904	CcSEcCtD
Ezogabine—Dermatitis—Capecitabine—stomach cancer	0.000127	0.000903	CcSEcCtD
Ezogabine—Paraesthesia—Epirubicin—stomach cancer	0.000126	0.000897	CcSEcCtD
Ezogabine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000126	0.000893	CcSEcCtD
Ezogabine—Dyspnoea—Epirubicin—stomach cancer	0.000125	0.00089	CcSEcCtD
Ezogabine—Somnolence—Epirubicin—stomach cancer	0.000125	0.000888	CcSEcCtD
Ezogabine—Nausea—Docetaxel—stomach cancer	0.000124	0.000879	CcSEcCtD
Ezogabine—Feeling abnormal—Methotrexate—stomach cancer	0.000124	0.000879	CcSEcCtD
Ezogabine—Dyspepsia—Epirubicin—stomach cancer	0.000124	0.000879	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000121	0.000862	CcSEcCtD
Ezogabine—Fatigue—Epirubicin—stomach cancer	0.000121	0.000861	CcSEcCtD
Ezogabine—Constipation—Epirubicin—stomach cancer	0.00012	0.000854	CcSEcCtD
Ezogabine—Nausea—Capecitabine—stomach cancer	0.00012	0.000851	CcSEcCtD
Ezogabine—Paraesthesia—Doxorubicin—stomach cancer	0.000117	0.00083	CcSEcCtD
Ezogabine—Dyspnoea—Doxorubicin—stomach cancer	0.000116	0.000824	CcSEcCtD
Ezogabine—Feeling abnormal—Epirubicin—stomach cancer	0.000116	0.000823	CcSEcCtD
Ezogabine—Somnolence—Doxorubicin—stomach cancer	0.000116	0.000821	CcSEcCtD
Ezogabine—Dyspepsia—Doxorubicin—stomach cancer	0.000114	0.000813	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000112	0.000798	CcSEcCtD
Ezogabine—Fatigue—Doxorubicin—stomach cancer	0.000112	0.000797	CcSEcCtD
Ezogabine—Constipation—Doxorubicin—stomach cancer	0.000111	0.00079	CcSEcCtD
Ezogabine—Asthenia—Methotrexate—stomach cancer	0.000108	0.000766	CcSEcCtD
Ezogabine—Feeling abnormal—Doxorubicin—stomach cancer	0.000107	0.000761	CcSEcCtD
Ezogabine—Asthenia—Epirubicin—stomach cancer	0.000101	0.000716	CcSEcCtD
Ezogabine—Dizziness—Methotrexate—stomach cancer	9.93e-05	0.000706	CcSEcCtD
Ezogabine—Rash—Methotrexate—stomach cancer	9.46e-05	0.000673	CcSEcCtD
Ezogabine—Dermatitis—Methotrexate—stomach cancer	9.46e-05	0.000672	CcSEcCtD
Ezogabine—Asthenia—Doxorubicin—stomach cancer	9.33e-05	0.000663	CcSEcCtD
Ezogabine—Dizziness—Epirubicin—stomach cancer	9.29e-05	0.00066	CcSEcCtD
Ezogabine—Nausea—Methotrexate—stomach cancer	8.92e-05	0.000634	CcSEcCtD
Ezogabine—Rash—Epirubicin—stomach cancer	8.86e-05	0.00063	CcSEcCtD
Ezogabine—Dermatitis—Epirubicin—stomach cancer	8.85e-05	0.000629	CcSEcCtD
Ezogabine—Dizziness—Doxorubicin—stomach cancer	8.6e-05	0.000611	CcSEcCtD
Ezogabine—Nausea—Epirubicin—stomach cancer	8.34e-05	0.000593	CcSEcCtD
Ezogabine—Rash—Doxorubicin—stomach cancer	8.2e-05	0.000583	CcSEcCtD
Ezogabine—Dermatitis—Doxorubicin—stomach cancer	8.19e-05	0.000582	CcSEcCtD
Ezogabine—Nausea—Doxorubicin—stomach cancer	7.72e-05	0.000549	CcSEcCtD
Ezogabine—UGT1A9—Metabolism—NDUFS1—stomach cancer	5.64e-05	0.000553	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NT5E—stomach cancer	5.51e-05	0.00054	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PGAM1—stomach cancer	5.51e-05	0.00054	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	5.51e-05	0.00054	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—stomach cancer	5.5e-05	0.000539	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MAPK3—stomach cancer	5.44e-05	0.000533	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MAPK3—stomach cancer	5.44e-05	0.000533	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ERBB2—stomach cancer	5.33e-05	0.000522	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—ERBB2—stomach cancer	5.33e-05	0.000522	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TYMP—stomach cancer	5.3e-05	0.00052	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—FADS1—stomach cancer	5.3e-05	0.00052	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALDH7A1—stomach cancer	5.26e-05	0.000516	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLCE1—stomach cancer	5.26e-05	0.000516	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MAPK1—stomach cancer	5.18e-05	0.000507	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MAPK1—stomach cancer	5.18e-05	0.000507	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—EGFR—stomach cancer	5.17e-05	0.000507	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—EGFR—stomach cancer	5.17e-05	0.000507	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GMPR2—stomach cancer	5.11e-05	0.000501	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CD44—stomach cancer	5.1e-05	0.0005	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—UMPS—stomach cancer	5.04e-05	0.000494	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BLVRB—stomach cancer	5.03e-05	0.000493	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PGLS—stomach cancer	5.03e-05	0.000493	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BLVRB—stomach cancer	5.03e-05	0.000493	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PGLS—stomach cancer	5.03e-05	0.000493	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SREBF2—stomach cancer	4.96e-05	0.000487	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—RORA—stomach cancer	4.91e-05	0.000481	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—KRAS—stomach cancer	4.89e-05	0.000479	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—KRAS—stomach cancer	4.89e-05	0.000479	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPAP2A—stomach cancer	4.8e-05	0.00047	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPAP2A—stomach cancer	4.8e-05	0.00047	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PDHA1—stomach cancer	4.69e-05	0.00046	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ECHS1—stomach cancer	4.69e-05	0.00046	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—HRAS—stomach cancer	4.68e-05	0.000459	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—HRAS—stomach cancer	4.68e-05	0.000459	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SUCLG1—stomach cancer	4.68e-05	0.000458	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—IDH3B—stomach cancer	4.68e-05	0.000458	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.61e-05	0.000452	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALDOB—stomach cancer	4.6e-05	0.000451	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MMP9—stomach cancer	4.57e-05	0.000448	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MMP9—stomach cancer	4.57e-05	0.000448	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TYMP—stomach cancer	4.41e-05	0.000432	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—FADS1—stomach cancer	4.41e-05	0.000432	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NDUFS1—stomach cancer	4.35e-05	0.000426	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NDUFV1—stomach cancer	4.35e-05	0.000426	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPP2R1A—stomach cancer	4.34e-05	0.000425	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALOX5—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA1—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CKB—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA1—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CKB—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NDUFA2—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FBP1—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NDUFA2—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FBP1—stomach cancer	4.27e-05	0.000419	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTP1—stomach cancer	4.25e-05	0.000417	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—DPYD—stomach cancer	4.2e-05	0.000412	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HMOX1—stomach cancer	4.19e-05	0.000411	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—HRAS—stomach cancer	4.16e-05	0.000407	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—HRAS—stomach cancer	4.16e-05	0.000407	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SREBF2—stomach cancer	4.13e-05	0.000405	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—stomach cancer	4.1e-05	0.000402	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—stomach cancer	4.1e-05	0.000402	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—RORA—stomach cancer	4.08e-05	0.0004	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—STAT3—stomach cancer	4.06e-05	0.000398	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—STAT3—stomach cancer	4.06e-05	0.000398	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLIN2—stomach cancer	4.02e-05	0.000394	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLIN2—stomach cancer	4.02e-05	0.000394	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—stomach cancer	3.98e-05	0.00039	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—stomach cancer	3.98e-05	0.00039	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TYMS—stomach cancer	3.95e-05	0.000388	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA2—stomach cancer	3.91e-05	0.000383	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA2—stomach cancer	3.91e-05	0.000383	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTM1—stomach cancer	3.91e-05	0.000383	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK3—stomach cancer	3.88e-05	0.000381	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK3—stomach cancer	3.88e-05	0.000381	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BLVRB—stomach cancer	3.87e-05	0.00038	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PGLS—stomach cancer	3.87e-05	0.00038	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALDOB—stomach cancer	3.82e-05	0.000375	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NT5E—stomach cancer	3.81e-05	0.000373	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NT5E—stomach cancer	3.81e-05	0.000373	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PGAM1—stomach cancer	3.81e-05	0.000373	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PGAM1—stomach cancer	3.81e-05	0.000373	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTT1—stomach cancer	3.72e-05	0.000365	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPAP2A—stomach cancer	3.7e-05	0.000362	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK1—stomach cancer	3.69e-05	0.000362	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK1—stomach cancer	3.69e-05	0.000362	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—EGFR—stomach cancer	3.69e-05	0.000362	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—EGFR—stomach cancer	3.69e-05	0.000362	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2A6—stomach cancer	3.68e-05	0.00036	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ERCC2—stomach cancer	3.68e-05	0.00036	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLCE1—stomach cancer	3.63e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDH7A1—stomach cancer	3.63e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLCE1—stomach cancer	3.63e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDH7A1—stomach cancer	3.63e-05	0.000356	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKR1C3—stomach cancer	3.58e-05	0.00035	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALOX5—stomach cancer	3.55e-05	0.000348	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—stomach cancer	3.52e-05	0.000345	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—stomach cancer	3.52e-05	0.000345	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—DPYD—stomach cancer	3.5e-05	0.000343	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—KRAS—stomach cancer	3.49e-05	0.000342	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—KRAS—stomach cancer	3.49e-05	0.000342	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO1—stomach cancer	3.48e-05	0.000342	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—UMPS—stomach cancer	3.48e-05	0.000342	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—UMPS—stomach cancer	3.48e-05	0.000342	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—stomach cancer	3.45e-05	0.000339	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA1—stomach cancer	3.29e-05	0.000323	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CKB—stomach cancer	3.29e-05	0.000323	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FBP1—stomach cancer	3.29e-05	0.000323	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NDUFA2—stomach cancer	3.29e-05	0.000323	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PDHA1—stomach cancer	3.24e-05	0.000318	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PDHA1—stomach cancer	3.24e-05	0.000318	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ECHS1—stomach cancer	3.24e-05	0.000318	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ECHS1—stomach cancer	3.24e-05	0.000318	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CAV1—stomach cancer	3.19e-05	0.000312	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOA1—stomach cancer	3.18e-05	0.000312	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLIN2—stomach cancer	3.1e-05	0.000304	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTT1—stomach cancer	3.09e-05	0.000303	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CD44—stomach cancer	3.09e-05	0.000303	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2A6—stomach cancer	3.05e-05	0.0003	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TYMP—stomach cancer	3.05e-05	0.000299	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FADS1—stomach cancer	3.05e-05	0.000299	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TYMP—stomach cancer	3.05e-05	0.000299	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FADS1—stomach cancer	3.05e-05	0.000299	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA2—stomach cancer	3.01e-05	0.000295	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKR1C3—stomach cancer	2.97e-05	0.000291	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—HRAS—stomach cancer	2.97e-05	0.000291	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—HRAS—stomach cancer	2.97e-05	0.000291	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NT5E—stomach cancer	2.94e-05	0.000288	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PGAM1—stomach cancer	2.94e-05	0.000288	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO1—stomach cancer	2.9e-05	0.000284	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SREBF2—stomach cancer	2.85e-05	0.00028	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SREBF2—stomach cancer	2.85e-05	0.00028	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—stomach cancer	2.84e-05	0.000278	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—stomach cancer	2.84e-05	0.000278	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—RORA—stomach cancer	2.82e-05	0.000276	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—RORA—stomach cancer	2.82e-05	0.000276	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—stomach cancer	2.8e-05	0.000275	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDH7A1—stomach cancer	2.8e-05	0.000275	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLCE1—stomach cancer	2.8e-05	0.000275	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UMPS—stomach cancer	2.69e-05	0.000263	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDOB—stomach cancer	2.64e-05	0.000259	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDOB—stomach cancer	2.64e-05	0.000259	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPP2R1A—stomach cancer	2.63e-05	0.000258	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTP1—stomach cancer	2.58e-05	0.000253	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CD44—stomach cancer	2.57e-05	0.000252	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMOX1—stomach cancer	2.54e-05	0.000249	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—stomach cancer	2.52e-05	0.000247	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ECHS1—stomach cancer	2.5e-05	0.000245	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PDHA1—stomach cancer	2.5e-05	0.000245	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.49e-05	0.000244	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.48e-05	0.000244	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALOX5—stomach cancer	2.45e-05	0.000241	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALOX5—stomach cancer	2.45e-05	0.000241	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—DPYD—stomach cancer	2.41e-05	0.000237	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—DPYD—stomach cancer	2.41e-05	0.000237	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NOS3—stomach cancer	2.41e-05	0.000236	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TYMS—stomach cancer	2.4e-05	0.000235	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—stomach cancer	2.37e-05	0.000232	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TYMP—stomach cancer	2.35e-05	0.00023	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FADS1—stomach cancer	2.35e-05	0.00023	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ERCC2—stomach cancer	2.23e-05	0.000218	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—stomach cancer	2.2e-05	0.000216	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SREBF2—stomach cancer	2.2e-05	0.000216	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.19e-05	0.000215	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPP2R1A—stomach cancer	2.18e-05	0.000214	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—RORA—stomach cancer	2.17e-05	0.000213	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTP1—stomach cancer	2.14e-05	0.00021	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTT1—stomach cancer	2.14e-05	0.000209	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTT1—stomach cancer	2.14e-05	0.000209	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMOX1—stomach cancer	2.11e-05	0.000207	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2A6—stomach cancer	2.11e-05	0.000207	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2A6—stomach cancer	2.11e-05	0.000207	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—stomach cancer	2.09e-05	0.000205	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKR1C3—stomach cancer	2.05e-05	0.000201	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKR1C3—stomach cancer	2.05e-05	0.000201	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDOB—stomach cancer	2.04e-05	0.0002	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO1—stomach cancer	2e-05	0.000196	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO1—stomach cancer	2e-05	0.000196	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TYMS—stomach cancer	1.99e-05	0.000195	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—stomach cancer	1.97e-05	0.000193	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.97e-05	0.000193	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAV1—stomach cancer	1.93e-05	0.000189	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOA1—stomach cancer	1.93e-05	0.000189	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALOX5—stomach cancer	1.89e-05	0.000186	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—DPYD—stomach cancer	1.86e-05	0.000183	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ERCC2—stomach cancer	1.85e-05	0.000181	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CD44—stomach cancer	1.77e-05	0.000174	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CD44—stomach cancer	1.77e-05	0.000174	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—stomach cancer	1.74e-05	0.000171	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.72e-05	0.000169	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—stomach cancer	1.7e-05	0.000166	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTT1—stomach cancer	1.65e-05	0.000161	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAV1—stomach cancer	1.6e-05	0.000157	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOA1—stomach cancer	1.6e-05	0.000157	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKR1C3—stomach cancer	1.58e-05	0.000155	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO1—stomach cancer	1.54e-05	0.000151	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—stomach cancer	1.53e-05	0.00015	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPP2R1A—stomach cancer	1.51e-05	0.000148	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPP2R1A—stomach cancer	1.51e-05	0.000148	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTP1—stomach cancer	1.48e-05	0.000145	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTP1—stomach cancer	1.48e-05	0.000145	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NOS3—stomach cancer	1.46e-05	0.000143	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMOX1—stomach cancer	1.46e-05	0.000143	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMOX1—stomach cancer	1.46e-05	0.000143	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—stomach cancer	1.41e-05	0.000138	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TYMS—stomach cancer	1.38e-05	0.000135	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TYMS—stomach cancer	1.38e-05	0.000135	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CD44—stomach cancer	1.37e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—stomach cancer	1.36e-05	0.000133	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—stomach cancer	1.36e-05	0.000133	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CA—stomach cancer	1.36e-05	0.000133	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—stomach cancer	1.34e-05	0.000131	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ERCC2—stomach cancer	1.28e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ERCC2—stomach cancer	1.28e-05	0.000125	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—stomach cancer	1.27e-05	0.000124	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NOS3—stomach cancer	1.21e-05	0.000119	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—stomach cancer	1.2e-05	0.000118	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—stomach cancer	1.2e-05	0.000118	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPP2R1A—stomach cancer	1.16e-05	0.000114	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTP1—stomach cancer	1.14e-05	0.000112	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMOX1—stomach cancer	1.13e-05	0.00011	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—stomach cancer	1.11e-05	0.000109	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAV1—stomach cancer	1.11e-05	0.000109	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAV1—stomach cancer	1.11e-05	0.000109	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOA1—stomach cancer	1.11e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOA1—stomach cancer	1.11e-05	0.000108	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TYMS—stomach cancer	1.06e-05	0.000104	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.06e-05	0.000104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—stomach cancer	1.05e-05	0.000103	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ERCC2—stomach cancer	9.86e-06	9.66e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—stomach cancer	9.75e-06	9.56e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—stomach cancer	9.75e-06	9.56e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—stomach cancer	9.27e-06	9.08e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—stomach cancer	8.76e-06	8.59e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—stomach cancer	8.76e-06	8.59e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAV1—stomach cancer	8.55e-06	8.38e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOA1—stomach cancer	8.53e-06	8.36e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NOS3—stomach cancer	8.38e-06	8.22e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NOS3—stomach cancer	8.38e-06	8.22e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CA—stomach cancer	8.21e-06	8.05e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—stomach cancer	7.67e-06	7.52e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—stomach cancer	7.67e-06	7.52e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—stomach cancer	7.51e-06	7.37e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CA—stomach cancer	6.83e-06	6.69e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—stomach cancer	6.76e-06	6.62e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NOS3—stomach cancer	6.46e-06	6.34e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—stomach cancer	5.91e-06	5.8e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CA—stomach cancer	4.72e-06	4.63e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CA—stomach cancer	4.72e-06	4.63e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CA—stomach cancer	3.64e-06	3.57e-05	CbGpPWpGaD
